Lily Wu, MD, PhD
Dr. Wu is a Professor in the Departments of Molecular and Medical Pharmacology, Urology, and Pediatrics. Following her undergraduate education at the University of California, Berkeley, Dr. Wu was a member of the inaugural class of the UCLA Medical Scientist Training Program (M.D., Ph.D. program). With completion of a UCLA Pediatrics Residency and UCLA Hematology Oncology Fellowship, Dr. Wu was a Howard Hughes Medical Institute (HHMI) Postdoctoral Fellow.
Junhui Hu, MD, PhD
Junhui is currently an Assistant Project Scientist in the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles (UCLA). During Junhui’s training as a research physician he developed broad interests on cancer research but mainly in the scope of how tumor heterogeneity contributes cancer progression and metastasis.
Moe received her B.S. from UCLA in Molecular, Cell, and Developmental Biology with a minor in Bioinformatics in 2017. After studying the multipotency of oligodendrocyte progenitor cells in her undergraduate research, she currently focuses on studying the metastatic mechanisms driven by VHL heterogeneity in kidney cancer.
Neal Patel, MD
Dr. Patel received his medical degree from George Washington University and subsequently completed his residency in Urology at New York Presbyterian Hospital-Weill Cornell Medicine. Having completed the clinical portion of his fellowship, Dr. Patel will spend the upcoming academic year performing translation kidney cancer research under the guidance of Dr. Brian Shuch, Dr. Lily Wu and Dr. David Shackelford.